A team of British researchers, led by scientists at the universities of Cambridge and Southampton in the United Kingdom, has developed the first vaccine designed entirely by artificial intelligence (AI) to be tested in humans.
“Viruses like Influenza, Coronaviruses and the Ebola group are evolving continuously, and by the time vaccines are rolled out, they may be poorly matched — the current “reactive” vaccine system struggles to keep pace,” said professor Saul Faust from the University of Southampton, the trial’s chief investigator.
